CommScope Reports Strong Q3 2025 Results, Raises Guidance and Confirms CCS Sale

COMM
October 31, 2025

CommScope Holding Company, Inc. reported third‑quarter 2025 financial results that included consolidated net sales of $1.6297 billion, a 50.6% increase year‑over‑year, and non‑GAAP adjusted EBITDA of $402.5 million, the highest quarterly figure in the company’s history.

Core operating income turned positive at $106.9 million, compared with a $96.7 million loss in the same period a year earlier. Segment performance was strong: RUCKUS net sales rose 15.2% to $178.5 million with adjusted EBITDA of $36 million; ANS net sales surged 77.2% to $337.8 million; and CCS net sales grew 51.1% to $1.1134 billion with adjusted EBITDA of $311.9 million.

Cash and liquidity improved markedly, with the company adding $134 million to its balance sheet and ending the quarter with $705 million in cash and cash equivalents. Order rates declined 8% sequentially, and backlog fell 8% from the second quarter.

Management raised its 2025 consolidated adjusted EBITDA target to $1.30–$1.35 billion and its RemainCo adjusted EBITDA guidance to $350–$375 million, citing strong demand from data centers and broadband upgrade cycles as key drivers.

The pending sale of the Connectivity and Cable Solutions (CCS) business to Amphenol for $10.5 billion in cash was approved by shareholders on October 16 and is expected to close in the first quarter of 2026. Proceeds will be used to repay debt, redeem preferred equity, and issue a special dividend within 60 to 90 days of the transaction.

CEO Chuck Treadway praised the results and the transformative nature of the CCS sale, while CFO Kyle Lorentzen highlighted the company’s sequential and year‑over‑year growth in adjusted EBITDA.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.